Abstract
Cardiovascular diseases and metabolic disorders are the most common groups of
disease in Eastern Europe. Moreover, poor housing standards have exacerbated
the spread of communicable diseases such as tuberculosis, diphtheria and
cholera. In Eastern European countries, the rising expenditure on prescription
pharmaceuticals is the leading contributor to increasing pressure on
healthcare finances, and has therefore been a major catalyst for healthcare
reforms. The Eastern European Pharmaceutical Market Outlook to 2014 provides a
comprehensive coverage of the Eastern European pharmaceutical market,
reviewing the market structure, pricing and regulation and includes detailed
epidemiological analyses of the common indications. This report makes a
wide-ranging assessment of the marketed product portfolio, R&D pipeline,
market share data, sales forecast and competitive landscape for the major
players in Eastern European market.
| 
View Cart
